WebCyprotex. Jun 2024 - Present2 years 9 months. • Management of R&D projects and commercial toxicology studies. • Cell culture of a broad range of cell types, including 2D and 3D models. • High-throughput in vitro toxicology assays, such as High Content Imaging (HCI), cytotoxicity assays. and extracellular flux analysis (Agilent Seahorse). WebOct 1, 2014 · Cyprotex is committed to research in this field to help our clients bring safer drugs to the market. By investing in the ArrayScanTM XTI and the Seahorse XFe we are …
Felix von Haniel - SVP Business Development - Cyprotex - LinkedIn
WebOct 9, 2012 · cyprotex @cyprotex We are the world leader in predictive toxicology and ADME research with several proprietary technologies and laboratories in the UK and US. cyprotex.com Joined October 2012 58 Following 756 Followers Replies Media cyprotex @cyprotex · Mar 9 New webinar hosted by @WatersCorp WebOct 26, 2016 · Evotec will pay approximately £ 55.36 m (EUR 62.00 m; £/EUR exchange rate of 1.12) in cash for the acquisition of all 26.1 million issued and to be issued Cyprotex shares and the funding of all existing company debt. The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. free web page widgets
Seahorses – Alyssa
WebThe Agilent Seahorse XF Mito Tox Assay kit allows for the identification of drug-induced mitochondrial toxicity through direct functional measurements of mitochondrial oxygen … WebExceptional business development, marketing and research background, possessing superb communication skills and an ability to establish sustainable and profitable relationships. Experience... Cyprotex’s functional mitochondrial toxicity service is a cell based assay which uses the Seahorse XF e extracellular flux analyzer is in Cyprotex's portfolio of in vitro toxicology services for measuring potential mitochondrial toxicity. Cyprotex deliver consistent, high quality data with the flexibility to adapt protocols based on specific ... fashion icons 60s